China SXT Pharmaceuticals, Inc. Shareholders' Equity
China SXT Pharmaceuticals, Inc. (SXTC) had Shareholders' Equity of $29.71 million as of 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-07-01
- 2026-03-31: Stockholders' Equity Attributable to Parent $29.71M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $20.23M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $15.44M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $15.03M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-03-31 | $29.71M 20-F · filed 2026-07-01 | |
| 2025-09-30 | $20.23M 6-K · filed 2025-12-31 | |
| 2025-03-31 | $15.44M 20-F · filed 2026-07-01 | |
| 2024-09-30 | $15.03M 6-K · filed 2025-12-31 | |
| 2024-03-31 | $13.93M 20-F · filed 2026-07-01 | |
| 2023-09-30 | $5.08M 6-K · filed 2025-03-28 | |
| 2023-03-31 | $14.69M 20-F · filed 2026-07-01 | |
| 2022-09-30 | $14.55M 6-K · filed 2024-04-05 | $14.89M 6-K · filed 2023-02-24 |
| 2022-03-31 | $16.08M 20-F · filed 2025-07-31 | $16.42M 20-F · filed 2022-07-18 |
| 2021-09-30 | $13.79M 6-K · filed 2023-02-24 | |
| 2021-03-31 | $15.96M 20-F · filed 2024-08-13 | |
| 2020-09-30 | $18.52M 6-K · filed 2022-01-14 | |
| 2020-03-31 | $9.40M 20-F · filed 2023-07-31 | |
| 2019-09-30 | $11.41M 6-K · filed 2021-01-28 | |
| 2019-03-31 | $11.11M 20-F/A · filed 2023-05-19 | |
| 2018-09-30 | $4.60M 6-K/A · filed 2020-05-22 | |
| 2018-03-31 | $3.29M 20-F · filed 2021-08-13 | |
| 2017-03-31 | $1.85M 20-F · filed 2020-07-31 | |
| 2016-03-31 | $742.77K 20-F · filed 2019-08-15 |